中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
26期
73-74
,共2页
肾性贫血%促红细胞生成素%左卡尼汀%效果
腎性貧血%促紅細胞生成素%左卡尼汀%效果
신성빈혈%촉홍세포생성소%좌잡니정%효과
Renal anemia%Erythropoietin%L-carnitine%Effect
目的：观察左卡尼汀联合促红细胞生成素治疗肾性贫血的效果。方法研究对象取2014年3月～2015年3月本院肾性贫血64例，依照治疗用药差异将其分组。给予对照组促红细胞生成素，共32例；在该基础上，给予实验组左卡尼汀，共32例。观察比较疗效。结果组间治疗有效率比较，对照组治疗有效率81.25%，无效6例，8例好转，10例有效，8例显效。实验组治疗有效率93.75%，无效2例，7例好转，11例有效，12例显效。组间比较，实验组高，有显著性差异（P＜0.05）。结论左卡尼汀联合促红细胞生成素治疗肾性贫血效果可靠，有效率高。
目的：觀察左卡尼汀聯閤促紅細胞生成素治療腎性貧血的效果。方法研究對象取2014年3月～2015年3月本院腎性貧血64例，依照治療用藥差異將其分組。給予對照組促紅細胞生成素，共32例；在該基礎上，給予實驗組左卡尼汀，共32例。觀察比較療效。結果組間治療有效率比較，對照組治療有效率81.25%，無效6例，8例好轉，10例有效，8例顯效。實驗組治療有效率93.75%，無效2例，7例好轉，11例有效，12例顯效。組間比較，實驗組高，有顯著性差異（P＜0.05）。結論左卡尼汀聯閤促紅細胞生成素治療腎性貧血效果可靠，有效率高。
목적：관찰좌잡니정연합촉홍세포생성소치료신성빈혈적효과。방법연구대상취2014년3월～2015년3월본원신성빈혈64례，의조치료용약차이장기분조。급여대조조촉홍세포생성소，공32례；재해기출상，급여실험조좌잡니정，공32례。관찰비교료효。결과조간치료유효솔비교，대조조치료유효솔81.25%，무효6례，8례호전，10례유효，8례현효。실험조치료유효솔93.75%，무효2례，7례호전，11례유효，12례현효。조간비교，실험조고，유현저성차이（P＜0.05）。결론좌잡니정연합촉홍세포생성소치료신성빈혈효과가고，유효솔고。
Objective To observe the efect of levocarnitine and erythropoietin in the treatment of renal anemia efect.Methods 64 cases of renal anemia in our hospital from March 2015 to March 2014 were studied. The control group were given erythropoietin, a total of 32 cases; on this basis, given the experimental group of L-carnitine, a total of 32 cases. Comparison of eficacy.Results The efective rate of the treatment group was, the efective rate was 81.25%, 6 cases were inefective, 8 cases improved, 10 cases were efective, 8 cases were markedly efective. The efective rate of treatment group was 93.75%, 2 cases were invalid, 7 cases improved, 11 cases were efective, 12 cases were markedly efective. Between groups, the experimental group was high, there were significant diferences (P<0.05).Conclusion Levocarnitine and erythropoietin treatment of renal anemia is reliable, high eficiency.
